The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on GLIOF as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLIOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GLIOF broke above its upper Bollinger Band on November 22, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GLIOF entered a downward trend on December 09, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.804) is normal, around the industry mean (6.876). P/E Ratio (0.000) is within average values for comparable stocks, (83.742). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.405). GLIOF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.040). P/S Ratio (0.000) is also within normal values, averaging (140.038).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GLIOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLIOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry PreciousMetals
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PTMAX | 21.59 | N/A | N/A |
PGIM Quant Solutions Large-Cap Cor Eq A | |||
BGCSX | 15.13 | N/A | N/A |
Baillie Gifford EAFE Plus All Cap I | |||
GBLEX | 38.22 | -0.81 | -2.08% |
American Funds Global Balanced F1 | |||
MSFBX | 32.59 | -0.71 | -2.13% |
Morgan Stanley Inst Global Franchise A | |||
TIRGX | 16.83 | -0.59 | -3.39% |
T. Rowe Price Global Real Estate I |
A.I.dvisor tells us that GLIOF and OSIIF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLIOF and OSIIF's prices will move in lockstep.
Ticker / NAME | Correlation To GLIOF | 1D Price Change % | ||
---|---|---|---|---|
GLIOF | 100% | -7.12% | ||
OSIIF - GLIOF | 23% Poorly correlated | N/A | ||
BXXRF - GLIOF | 22% Poorly correlated | N/A | ||
GGGOF - GLIOF | 20% Poorly correlated | -9.28% | ||
GORIF - GLIOF | 2% Poorly correlated | N/A | ||
GNGXF - GLIOF | 0% Poorly correlated | N/A | ||
More |